STAAR Surgical Company (STAA) Stock Forecast & Price Target
STAAR Surgical Company · NASDAQ
$22.95-0.43 (-1.84%)
15-min delayed · Jul 27, 3:45 PM ET · Get real-time quotes →
The Quantellect read.Of the 8 firms covering STAAR Surgical Company, 3 rate it Buy or better, 5 sit at Hold, and 0 rate it Sell or worse, a hold consensus. Targets span $21.50 to $40.00, a moderate spread. The average target of $29.69 sits 29% above the current $22.95. The rating mix has stayed broadly stable, with Buy-side ratings edging up from 2 to 3 over recent months. On the fundamentals, the Street sees revenue growth near 29% this year and 8% next, consensus EPS building from about $0.17 next quarter toward $0.99 the year after.Descriptive synthesis of third-party analyst data, not a Quantellect rating or recommendation.
ANALYST CONSENSUS8 ratings
Hold
Strong Buy00%
Buy338%
Hold563%
Sell00%
Strong Sell00%
Based on 8 analysts giving stock ratings to STAAR Surgical Company.
As of Jul, 3 of 8 firms rate STAA a Buy (5 Hold, 0 Sell), the standing distribution of every covering firm's most recent active call.
STAA EPS & revenue forecast
EPS · NEXT QUARTER
$0.17
Range $0.07 – $0.29 · 7 analysts · -64% YoY
Next period, 7 analysts expect STAAR Surgical Company to earn $0.17 a share (range $0.07 – $0.29), versus $0.47 a year earlier. Full-year consensus is $0.73, growing to $0.99 the year after.
REVENUE · NEXT QUARTER
$83.4M
Range $77.6M – $90.1M · 7 analysts · +88% YoY
Revenue is expected to reach $83.4M (range $77.6M – $90.1M), +88.0% year-over-year. Full-year consensus is $338.2M, rising to $361.5M next year.
Top analysts covering STAAR Surgical Company
Ranked by each analyst's overall Quantellect track record across all the stocks they cover, shown with their current call on STAA.
#1
David Saxon
Needham · Rank #264
Hold
$2026.00+8727.9% to target
Overall win rate
34%
+ Follow
#2
Matt O'Brien
Piper Sandler · Rank #356
Hold
$16.00-30.3% to target
Overall win rate
25%
+ Follow
#3
MP
Michael Piccolo
Wedbush
Buy
$40.00+74.3% to target
Coverage
—
+ Follow
#4
TS
Thomas Stephan
Stifel
Hold
$31.00+35.1% to target
Coverage
—
+ Follow
#5
JY
Jon Young
Canaccord Genuity
Hold
$28.00+22.0% to target
Coverage
—
+ Follow
STAA stock forecast FAQ
What is STAA's average 12-month price target?+
The 8 analysts with a live target average $29.69 for STAAR Surgical Company over the next 12 months, ranging from a $40.00 high to a $21.50 low.
Is STAA stock a Buy, Sell or Hold right now?+
The current consensus is Hold. Of the 8 analyst ratings, 3 are Buy or Strong Buy, 5 are Hold, and 0 are Sell or Strong Sell.
What are the highest and lowest price targets for STAA?+
The Street-high target is $40.00 (Wedbush), and the Street-low is $21.50 (Jefferies). The average of all 8 active targets is $29.69.
How many Wall Street analysts cover STAA?+
8 analysts have an active rating on STAAR Surgical Company, and 8 firms carry a live 12-month price target.
Who is the most accurate analyst covering STAA?+
Among analysts who currently cover STAA, David Saxon of Needham has the strongest overall Quantellect track record (Rank #264). Their current call is Hold with a $2026.00 target.
What is STAAR Surgical Company's projected EPS for next quarter?+
The consensus estimate is $0.17 per share (range $0.07 – $0.29) across 7 analysts. Full-year EPS is projected at $0.73, rising to $0.99 the following year.
How much revenue is STAAR Surgical Company expected to report next quarter?+
Consensus revenue is $83.4M (range $77.6M – $90.1M). Full-year revenue is projected at $338.2M, growing to $361.5M next year.
Have analysts been upgrading or downgrading STAA lately?+
As of Jul, 3 of 8 firms rate STAA a Buy (5 Hold, 0 Sell), the standing distribution of every covering firm's most recent active call.
How are the analysts on this page ranked?+
By each analyst's overall Quantellect track record — a sample-adjusted measure of how accurate their calls have been across every stock they cover. We do not rank on their STAA calls alone, since a single stock is too small a sample to be reliable.
Which data on this page is live, and how often does it update?+
Price and daily change are 15-minute delayed market data. Analyst ratings, targets, consensus and earnings estimates are aggregated from multiple data providers and refresh daily.
Disclaimer: Ratings, price targets, consensus and earnings estimates on this page describe third-party analyst research aggregated from multiple data providers and refreshed daily; price and daily change are 15-minute delayed. These are historical opinions, not recommendations, and nothing on this page, including The Quantellect read, is a rating, a price target, or investment advice from Quantellect. Always do your own research and consult a licensed financial advisor before making investment decisions.
